Delaware’s DNA | 2023 Life Science Conference
Join an unprecedented collection of life science leaders on Thursday May 11 for Delaware’s DNA: 2023 Life Science Conference. The event will convene regional and national biomedical researchers, business leaders, investors and policymakers for a day-long program of rich panel discussions and insightful speakers highlighting the momentum and opportunity underlining Delaware and the region’s emergence as a global hub of innovation and growth.
Conference headliners include Incyte CEO Hervé Hoppenot, Biotechnology Innovation Organization (BIO) interim CEO Rachel King, Aisling Capital founder Dennis Purcell, National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Director Kelvin Lee and Eric Kmiec, Director of the Gene Editing Institute and founder of CorriXR Therapeutics.
- May 11